Table 1.

Comparison between CDC-suggested tentative MIC breakpoints and antifungal susceptibility test from patient (and mother) isolated strains.

Drug	CDC Tentative MIC Breakpoints (µg/mL)	MIC from Patient Strain (µg/mL)
Fluconazole	≥32	>256
Voriconazole	N/A	2
Posaconazole	N/A	0.12
Itraconazole	N/A	2
Amphotericin B	≥ 2	1
Anidulafungin	≥ 4	0.25
Caspofungin	≥ 2	0.12
Micafungin	≥ 4	0.12